Funding for this research was provided by:
Juvenile Diabetes Research Foundation United States of America (9-2011-253, 2-APF-2017-420-A-N)
Wellcome Trust (WT061858, WT091157)
Text and Data Mining valid from 2018-07-27
Received: 16 February 2018
Accepted: 20 June 2018
First Online: 27 July 2018
Ethics approval and consent to participate
: All samples and information were collected with written and signed informed consent after approval from the relevant research ethics committees (REC numbers 05/Q0106/20, 07/H0718/49, 08/H0308/153; and NRES Committee London-Hampstead, HRA, REC number 6398).
: Not applicable.
: JJO is an employee of GlaxoSmithKline pharmaceuticals. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.